Marine Biotechnology Department, Stazione Zoologica Anton Dohrn, CAP, 80121 Naples, Italy.
Institute of Biosciences and BioResources (IBBR), National Research Council, Via Pietro Castellino 111, 80131 Naples, Italy.
Biomolecules. 2020 Jul 7;10(7):1007. doi: 10.3390/biom10071007.
Oceans cover more than 70 percent of the surface of our planet and are characterized by huge taxonomic and chemical diversity of marine organisms. Several studies have shown that marine organisms produce a variety of compounds, derived from primary or secondary metabolism, which may have antiviral activities. In particular, certain marine metabolites are active towards a plethora of viruses. Multiple mechanisms of action have been found, as well as different targets. This review gives an overview of the marine-derived compounds discovered in the last 10 years. Even if marine organisms produce a wide variety of different compounds, there is only one compound available on the market, Ara-A, and only another one is in phase I clinical trials, named Griffithsin. The recent pandemic emergency caused by SARS-CoV-2, also known as COVID-19, highlights the need to further invest in this field, in order to shed light on marine compound potentiality and discover new drugs from the sea.
海洋覆盖了地球表面的 70%以上,具有巨大的分类和化学多样性的海洋生物。多项研究表明,海洋生物产生多种化合物,来源于初级或次级代谢,可能具有抗病毒活性。特别是,某些海洋代谢物对多种病毒具有活性。已经发现了多种作用机制和不同的靶点。这篇综述概述了过去 10 年发现的海洋来源的化合物。即使海洋生物产生了各种各样的不同的化合物,只有一种化合物在市场上,Ara-A,只有另一种化合物处于 I 期临床试验,名为 Griffithsin。由 SARS-CoV-2 引起的最近的大流行紧急情况,也称为 COVID-19,突出表明需要进一步投资于这一领域,以揭示海洋化合物的潜力,并从海洋中发现新药。